Roosmarijn Vandenbroucke obtained her Bachelor’s degree in Biological Sciences and Master‘s degree in Biotechnology in 1999 and 2001, respectively at Ghent University (Belgium). Next, she obtained a fellowship from the IWT (Agency for Innovation by Science and Technology) and worked for almost two years in the lab of Prof. F. Van Roy (DMBR, Ghent University, Belgium) on ‘The role of Nanos in cancer development’.
In 2003, she started as a research assistant in the Ghent Research Group on Nanomedicines where she obtained a PhD in Pharmaceutical Sciences in 2008 on ‘Non-viral delivery strategies to guide therapeutic nucleic acids through cellular barriers’. In 2009, she obtained a fellowship from Ghent University (BOF) and one year later from the FWO (The Research Foundation – Flanders, Belgium) to start as a postdoctoral fellow at the VIB (Flanders Institute for Biotechnology) in the group of Prof. Claude Libert in the Inflammation Research Center (IRC). There, she focused on the role of matrix metalloproteinases (MMPs), tumor necrosis factor (TNF) and interferons (IFNs) in inflammatory disorders and gained a lot of expertise related to two epithelial barriers, the gut and brain choroid plexus epithelial barriers, in sepsis.
Currently, she guides a subgroup within the lab of Claude Libert consisting of 4 PhD students and 2 technicians and will start an independent group from Oct 1st 2015 on. The topic of her current research is 'The impact of inflammation on the gut and brain epithelial barrier, focusing on sepsis, (inflamm)aging and neurodegenerative diseases.'